NCT07860047
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07860047
Title Multi-peptide Vaccination and Bispecific PSMAxCD3 Antibody Treatment in Patients With Prostate Cancer (ImmProCure)
Acronym ImmProCure
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University Hospital Tuebingen
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.